I agree that this site is using cookies. You can find further informations here.
X
Rossi, Edmund A.
90  results:
Search for persons X
?
1

Correction: Trop-2 is a novel target for solid cancer thera..:

Goldenberg, David M. ; Cardillo, Thomas M. ; Govindan, Serengulam V...
Oncotarget.  11 (2020)  10 - p. 942-942 , 2020
Link: https://doi.org/10.18632..
 
?
2

Trop-2 is a novel target for solid cancer therapy with saci..:

Goldenberg, David M. ; Cardillo, Thomas M. ; Govindan, Serengulam V...
Oncotarget.  6 (2015)  26 - p. 22496-22512 , 2015
Link: https://doi.org/10.18632..
 
?
3

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Anti..:

Cardillo, Thomas M. ; Govindan, Serengulam V. ; Sharkey, Robert M....
Bioconjugate Chemistry.  26 (2015)  5 - p. 919-931 , 2015
Link: https://doi.org/10.1021/..
 
?
4

Predictive patient-specific dosimetry and individualized do..:

Schoffelen, Rafke ; Woliner-van der Weg, Wietske ; Visser, Eric P....
European Journal of Nuclear Medicine and Molecular Imaging.  , 2014
Link: https://doi.org/10.1007/..
 
?
5

Anti-CD22/CD20 Bispecific Antibody with Enhanced Trogocytos..:

Rossi, Edmund A. ; Chang, Chien-Hsing ; Goldenberg, David M..
PLoS ONE.  9 (2014)  5 - p. e98315 , 2014
Link: https://doi.org/10.1371/..
 
?
6

Trop-2-targeting tetrakis-ranpirnase has potent antitumor a..:

Liu, Donglin ; Cardillo, Thomas M ; Wang, Yang...
Molecular Cancer.  13 (2014)  1 - p. 53 , 2014
Link: https://doi.org/10.1186/..
 
?
7

Improving the Therapeutic Index in Cancer Therapy by Using ..:

Govindan, Serengulam V. ; Cardillo, Thomas M. ; Rossi, Edmund A....
Molecular Pharmaceutics.  12 (2014)  6 - p. 1836-1847 , 2014
Link: https://doi.org/10.1021/..
 
?
8

Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently ..:

Liu, Donglin ; Chang, Chien-Hsing ; Rossi, Edmund A....
PLoS ONE.  8 (2013)  5 - p. e63940 , 2013
Link: https://doi.org/10.1371/..
 
?
9

The Development of Bispecific Hexavalent Antibodies as a No..:

Chang, Chien-Hsing ; Rossi, Edmund ; Wang, Yang..
Antibodies.  2 (2013)  2 - p. 353-370 , 2013
Link: https://doi.org/10.3390/..
 
?
10

Pretargeted immuno-PET and radioimmunotherapy of prostate c..:

van Rij, Catharina M. ; Lütje, Susanne ; Frielink, Cathelijne...
European Journal of Nuclear Medicine and Molecular Imaging.  40 (2013)  9 - p. 1377-1383 , 2013
Link: https://doi.org/10.1007/..
 
?
11

Complex and defined biostructures with the dock-and-lock me..:

Rossi, Edmund A. ; Goldenberg, David M. ; Chang, Chien-Hsing
Trends in Pharmacological Sciences.  33 (2012)  9 - p. 474-481 , 2012
Link: https://doi.org/10.1016/..
 
?
12

The Dock-and-Lock Method Combines Recombinant Engineering w..:

Rossi, Edmund A. ; Goldenberg, David M. ; Chang, Chien-Hsing
Bioconjugate Chemistry.  23 (2012)  3 - p. 309-323 , 2012
Link: https://doi.org/10.1021/..
 
?
13

A Novel Class of Anti-HIV Agents with Multiple Copies of En..:

Chang, Chien-Hsing ; Hinkula, Jorma ; Loo, Meiyu...
PLoS ONE.  7 (2012)  7 - p. e41235 , 2012
Link: https://doi.org/10.1371/..
 
?
14

Pretargeting: taking an alternate route for localizing radi..:

Sharkey, Robert M. ; Chang, Chien-Hsing ; Rossi, Edmund A...
Tumor Biology.  33 (2012)  3 - p. 591-600 , 2012
Link: https://doi.org/10.1007/..
 
?
15

Pretargeted Molecular Imaging and Radioimmunotherapy:

Goldenberg, David M. ; Chang, Chien-Hsing ; Rossi, Edmund A...
Theranostics.  2 (2012)  5 - p. 523-540 , 2012
Link: https://doi.org/10.7150/..
 
1-15